Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

34.06B

Market cap34.06B

Price-Earnings ratio

14.09

Price-Earnings ratio14.09

Dividend yield

2.56%

Dividend yield2.56%

Average volume

5.75M

Average volume5.75M

High today

$83.87

High today$83.87

Low today

$82.27

Low today$82.27

Open price

$83.47

Open price$83.47

Volume

3.15M

Volume3.15M

52 Week high

$132.49

52 Week high$132.49

52 Week low

$68.77

52 Week low$68.77

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $83.87. The company's market cap stands at 34.06B, with a P/E ratio of 14.09 and a dividend yield of 2.56%.

During the trading session on 2026-11-13, Zoetis(ZTS) shares reached a daily high of $83.87 and a low of $82.27. At a current price of $83.87, the stock is +2.0% higher than the low and still 0.0% under the high.

Trading volume for Zoetis(ZTS) stock has reached 3.15M, versus its average volume of 5.75M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $132.49 and a low of $68.77.

ZTS News

Nikkei Asian Review 1d

Pfizer offshoot Zoetis lines up 'potential blockbuster' pet meds for Japan - Nikkei Asia

...

Simply Wall St 4d

Zoetis Cuts Its Revenue Outlook, Is The Stock Cheap?

Earnings setback and updated outlook put Zoetis in focus Zoetis (ZTS) stepped into the spotlight after reporting third quarter 2026 results that showed slightl...

Zacks 5d

ZTS Q3 Earnings Call Highlights Competitive Pressures and Outlook

Zoetis Inc. (ZTS Quick QuoteZTS - Free Report) emphasized market share protection, targeted pricing and innovation during its third-quarter 2026 earnings...

Analyst ratings

67%

of 18 ratings

Buy

33.3%

Hold

66.7%

Sell

More ZTS News

Simply Wall St 5d

Earnings Guidance Cut Might Change The Case For Investing In Zoetis

Zoetis reported third quarter 2026 results with sales of US$2,391 million and net income of US$591 million, with earnings per share from continuing operations a...

TipRanks 6d

Zoetis Earnings Call: Resilience Meets Persistent Pet-Care Pressure

Zoetis ((ZTS)) has held its Q3 earnings call. Read on for the main highlights of the call. Zoetis delivered a mixed third-quarter performance, combining resili...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.